Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Colorcon
McKinsey
Fish and Richardson
Harvard Business School
Fuji
McKesson
Boehringer Ingelheim
Medtronic

Generated: May 22, 2018

DrugPatentWatch Database Preview

DDAVP Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ddavp patents expire, and what generic alternatives are available?

Ddavp is a drug marketed by Ferring Pharms Inc and is included in three NDAs.

The generic ingredient in DDAVP is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Drug patent expirations by year for DDAVP
Synonyms for DDAVP
(2S)-N-[(2R)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-
(Deamino-Cys1,D-Arg8)-Vasopressin
(S)-1-((4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-((R)-1-(2-amino-2-oxoethylamino)-5-gua
(S)-1-((4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-((S)-1-(2-amino-2-oxoethylamino)-5-gua
[deamino-Cys1,D-Arg8]vasopressin
[deamino-Cys1]AVP
[deamino1]AVP
1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin
1-{[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-D-arginylglycinamide
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n5-(diaminomethylidene)ornithylglycinamide
1-Deamino-8-D-arginine vasopressin
1-deamino,D-AVP
1-Desamino-8-arginine Vasopressin
1-Desamino-8-D-arginine vasopressin
16679-58-6
3576AH
62288-83-9 (monoacetate)
62357-86-2 (monoacetate trihydrate)
679D586
6917-99-3
A810770
AC1L1EDS
AC1NSJXN
AC1Q5JBY
Adiuretin
Adiuretin SD
AKOS015994650
BDBM50205291
BDBM50205308
BDBM85094
C06944
C46H64N14O12S2
C4H10.CH2O
CAS_62357-86-2
CAS-16679-58-6
CD-644
CHEBI:4450
CHEMBL1429
CHEMBL264448
CHEMBL376685
CS-1199
D00291
D0N9GI
D0U7SH
D0Y7SJ
dAVP
DB00035
Deamino Arginine Vasopressin
deamino-[Cys1]arginine vasopressin
Deamino-8-D-arginine, l-, vasopressin
deamino-vasopressin
Desamino-8-D-arginine vasopressin, l-
Desmopresina
Desmopresina [INN-Spanish]
DESMOPRESSIN
Desmopressin (fast-dissolving, nocturia/diabetes insipidus)
Desmopressin (fast-dissolving, nocturia/diabetes insipidus), Ferring Pharmaceuticals
Desmopressin (INN)
Desmopressin [INN:BAN]
Desmopressin acetate
Desmopressin acetate hydrate
Desmopressin Melt
Desmopressin Monoacetate, Trihydrate
Desmopressine
Desmopressine [INN-French]
Desmopressinum
Desmopressinum [INN-Latin]
DSSTox_CID_28234
DSSTox_GSID_48259
DSSTox_RID_82746
DTXSID1048259
EINECS 240-726-7
ENR1LLB0FP
FE-992026
FT-0688024
GTPL2181
GTPL2182
HS-2010
HY-17370A
KS-00002WUQ
L001026
LS-173612
LS-187262
Minirin
minirinmelt
Minrin Melt
MolPort-006-069-425
N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-p
N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacyc
N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pen
N-[1-[(2-azanyl-2-oxidanylidene-ethyl)amino]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]-1-[[7-(2-azanyl-2-oxidanylidene-ethyl)-10-(3-azanyl-3-oxidanylidene-propyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-p
NCGC00181133-02
NFLWUMRGJYTJIN-PNIOQBSNSA-N
Noctiva
NSC_64759
SC-18848
SCHEMBL13575732
SCHEMBL14027607
SCHEMBL22510
Tox21_113379
UNII-ENR1LLB0FP
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-
Vasopressin, Deamino Arginine
W-5074

US Patents and Regulatory Information for DDAVP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-001 Mar 30, 1984 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 017922-003 Aug 7, 1996 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-002 Apr 25, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for DDAVP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-001 Mar 30, 1984 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-001 Mar 30, 1984 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-002 Sep 6, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Harvard Business School
Dow
US Army
McKesson
Julphar
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.